全文获取类型
收费全文 | 3519篇 |
免费 | 246篇 |
国内免费 | 23篇 |
专业分类
耳鼻咽喉 | 15篇 |
儿科学 | 191篇 |
妇产科学 | 43篇 |
基础医学 | 409篇 |
口腔科学 | 68篇 |
临床医学 | 339篇 |
内科学 | 896篇 |
皮肤病学 | 82篇 |
神经病学 | 134篇 |
特种医学 | 516篇 |
外科学 | 392篇 |
综合类 | 73篇 |
一般理论 | 2篇 |
预防医学 | 203篇 |
眼科学 | 27篇 |
药学 | 186篇 |
中国医学 | 4篇 |
肿瘤学 | 208篇 |
出版年
2021年 | 24篇 |
2020年 | 31篇 |
2019年 | 30篇 |
2018年 | 51篇 |
2017年 | 26篇 |
2016年 | 47篇 |
2015年 | 51篇 |
2014年 | 51篇 |
2013年 | 101篇 |
2012年 | 109篇 |
2011年 | 92篇 |
2010年 | 116篇 |
2009年 | 96篇 |
2008年 | 100篇 |
2007年 | 107篇 |
2006年 | 107篇 |
2005年 | 93篇 |
2004年 | 86篇 |
2003年 | 83篇 |
2002年 | 111篇 |
2001年 | 84篇 |
2000年 | 91篇 |
1999年 | 78篇 |
1998年 | 150篇 |
1997年 | 128篇 |
1996年 | 146篇 |
1995年 | 110篇 |
1994年 | 93篇 |
1993年 | 101篇 |
1992年 | 67篇 |
1991年 | 61篇 |
1990年 | 61篇 |
1989年 | 109篇 |
1988年 | 75篇 |
1987年 | 89篇 |
1986年 | 79篇 |
1985年 | 87篇 |
1984年 | 58篇 |
1983年 | 62篇 |
1982年 | 48篇 |
1981年 | 41篇 |
1980年 | 49篇 |
1979年 | 32篇 |
1978年 | 31篇 |
1977年 | 45篇 |
1976年 | 38篇 |
1975年 | 44篇 |
1974年 | 32篇 |
1973年 | 30篇 |
1972年 | 24篇 |
排序方式: 共有3788条查询结果,搜索用时 15 毫秒
1.
2.
3.
JA HYEON KU CHEOL KWAK SEUNG-JUNE OH EUNSIK LEE SANG EUN LEE JAE-SEUNG PAICK 《International journal of urology》2004,11(7):489-493
BACKGROUND: Our aims in the present study were to estimate the influences of pain and urinary symptoms on quality of life, and to determine which of these two variables has the most predictive power with respect to quality of life in young men with chronic prostatitis-like symptoms. METHODS: Chronic prostatitis-like symptoms were measured by the National Institutes of Health-Chronic Prostatitis Symptom Index. Of the 28,841 men aged 20 years who lived in the study community, 18,495 men (a response rate 64.1%) agreed to participate in the study. A total of 1057 men who complained of symptoms indicative of chronic prostatitis were included in the study. The influences of pain and urinary symptoms on quality of life were determined using logistic regression analysis. The receiver operating characteristic (ROC) curve was used to estimate the predictive ability of each of these variables with respect to quality of life. RESULTS: Results from multivariate analysis showed that both pain and urinary symptoms were associated with an increased likelihood of impaired quality of life, although pain contributed more to a reduced quality of life than urinary symptoms. Relative to men who experienced mild pain, men who experienced moderate pain had a 3.9-fold risk of poor quality of life (odds ratio [OR], 3.87; 95% confidence interval [CI], 2.86-5.23; P < 0.001) and those who experienced severe pain had a 15.7-fold risk of reduced quality of life (OR, 15.68; 95% CI, 6.59-37.35; P < 0.001). Moderate urinary symptoms were associated with a 1.4-fold risk of bother (OR, 1.41; 95% CI, 1.01-1.99; P < 0.001) and severe urinary symptoms were associated with 2.4-fold risk (OR, 2.39; 95% CI, 1.37-4.12; P < 0.001), relative to mild urinary symptoms. Comparison of the effects of pain and urinary symptoms showed that pain severity had the most predictive power for bother, quality of life, and quality-of-life impact. The areas under the ROC curves for bother, quality of life, and quality-of-life impact were 71.3%, 69.3% and 72.5%, respectively. CONCLUSION: Urinary symptoms and pain might be associated with an increased likelihood of impaired quality of life in young men with chronic prostatitis-like symptoms. In addition, our findings suggest that pain severity is the most influential variable for determining quality of life in this population. 相似文献
4.
5.
6.
7.
8.
9.
Cerebellar toxicity with high-dose cytosine arabinoside 总被引:1,自引:0,他引:1
R H Herzig J D Hines G P Herzig S N Wolff P A Cassileth H M Lazarus D J Adelstein R A Brown P F Coccia S Strandjord 《Journal of clinical oncology》1987,5(6):927-932
CNS dysfunction, especially impaired cerebellar function, is the dose-limiting toxicity associated with high-dose cytosine arabinoside, which precludes doses of greater than 48 g/m2. Four hundred eighteen patients between the ages of 2 and 74 years with leukemia or lymphoma received 36 to 48 g/m2 cytosine arabinoside either alone or with anthracycline antibiotics, 4'-(9-acridinylamino) methane sulfon-m-anisidine (m-AMSA), or total body irradiation. In only 35 of 418 patients (8%) did severe cerebellar toxicity develop; it was irreversible or fatal in four (1%) patients. The age of the patient was a critical factor in the incidence of severe cerebellar toxicity. Patients greater than 50 years old had a statistically significant greater incidence of cerebellar toxicity compared with younger patients (26/137, 19%, v 9/281, 3%; P less than .0005, chi 2). Neither the diagnosis, disease status, sex, nor the regimen altered the incidence of severe cerebellar toxicity (when corrected for age). A second course of high-dose cytosine arabinoside, administered to 62 patients, did not increase the incidence of severe cerebellar toxicity, which occurred in five (8%) of these patients. Two of the five patients had severe toxicity with the initial course. Of the 60 patients with no antecedent cerebellar dysfunction, three (5%) had severe toxicity with the second course: one of 41 patients were less than 50 years old; two of 19 patients were greater than or equal to 50 years. Since the occurrence of severe cerebellar dysfunction is greatly affected by age, reduced doses of high-dose cytosine arabinoside should be given to patients greater than 50 years old, and methods for reducing the cerebellar toxicity should be investigated in these patients. 相似文献
10.